Mar 1, 2021
In the third and final episode of our series on public hospital M&A, we discuss key regulatory considerations when executing public hospital M&A and planning for post-transaction success. McDermott partners Emily Cook and Megan Rooney are joined by Rex Burgdorfer, managing director at Juniper Advisory to discuss:
- Key regulatory approvals that hospitals must anticipate and address
- Public and government hospital considerations regarding successful 340B participation, including DSH percentage thresholds
- The significance of critical access hospital status to acquirers and steps hospitals can take to maintain this designation and receive the same benefits as larger systems
- Steps hospitals can take to drive quality and financial agreements and promote post-transaction success
- The importance of effectively communicating with employees prior to dealmaking and during the transition period
Catch Up on Past Episodes in This Series
“Driving the Deal: Public Hospital M & A and Stakeholder Buy-in”
“Dealmaking in the Sunlight: Navigating Public Hospital M&A”